Dokuz Eylül University is a university in İzmir, Turkey. It was founded in 1982 and is organized in 15 faculties. DEU is the first university which applied the problem-based learning method in Turkey, beginning in the School of Medicine in 1997.

During the past decade, Dokuz Eylül University conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 3 clinical trials were completed, i.e. on average, 4.3% percent of trials that started reached the finish line to date. In the past 5 years, 40 clinical trials started and 2 clinical trials were completed. i.e. 5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dokuz Eylül University" #1 sponsor was "Dokuz Eylul University" with 48 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Celgene" with 3 trials sponsored, "Abdi Ibrahim Ilac San. ve Tic A.S." with 1 trials sponsored and "Alector Inc." with 1 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dokuz Eylül University" #1 collaborator was "Dokuz Eylul University" with 7 trials as a collaborator, "Cukurova University" with 3 trials as a collaborator, "Izmir Katip Celebi University" with 3 trials as a collaborator, "Diskapi Yildirim Beyazit Education and Research Hospital" with 2 trials as a collaborator and "Gazi University" with 2 trials as a collaborator. Other collaborators include 55 different institutions and companies that were collaborators in the rest 62 trials.

According to Clinical.Site data, the most researched conditions in "Dokuz Eylül University" are "Healthy" (4 trials), "Multiple Sclerosis" (4 trials), "Ankylosing Spondylitis" (3 trials), "Covid19" (3 trials) and "Parkinson Disease" (3 trials). Many other conditions were trialed in "Dokuz Eylül University" in a lesser frequency.

Most popular intervention types in "Dokuz Eylül University" are "Other" (35 trials), "Drug" (16 trials), "Behavioral" (10 trials), "Device" (8 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Control group" (4 trials), "Inspiratory Muscle Training (IMT)" (2 trials), "Inspiratory muscle training" (2 trials) and "Mirikizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Dokuz Eylül University" are 71 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Dokuz Eylül University". undefined are not yet recruiting, 18 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 40 completed trials in Dokuz Eylül University, 1 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Dokuz Eylül University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 51 trials that are defined as “Not Applicable".

Dokuz Eylül University has several departments that took part in Clinical trials: "Dokuz Eylul University, School of Physical Therapy and Rehabilitation" - 16 trials, "Dokuz Eylül University, School of Medicine, Department of Anesthesiology and Reanimation" - 8 trials, "Dokuz Eylul Uni ; Medical Oncology" - 5 trials, "Dokuz Eylul Uni ; Hematology" - 5 trials, "Dokuz Eylul University Faculty of Medicine; Chest Diseases" - 2 trials, "Dokuz Eylul University Medicine Faculty; Noroloji Departmani" - 2 trials